Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Debt Ratio (2021 - 2026)

Axsome Therapeutics' Debt Ratio history spans 6 years, with the latest figure at 0.18 for Q1 2026.

  • On a quarterly basis, Debt Ratio fell 43.22% to 0.18 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.18, a 43.22% decrease, with the full-year FY2025 number at 0.19, down 41.73% from a year prior.
  • Debt Ratio hit 0.18 in Q1 2026 for Axsome Therapeutics, down from 0.19 in the prior quarter.
  • Over the last five years, Debt Ratio for AXSM hit a ceiling of 0.56 in Q1 2022 and a floor of 0.18 in Q1 2026.
  • Historically, Debt Ratio has averaged 0.32 across 5 years, with a median of 0.31 in 2023.
  • Biggest five-year swings in Debt Ratio: tumbled 45.97% in 2022 and later rose 13.52% in 2024.
  • Tracing AXSM's Debt Ratio over 5 years: stood at 0.3 in 2022, then grew by 3.79% to 0.31 in 2023, then increased by 1.36% to 0.32 in 2024, then plummeted by 41.73% to 0.19 in 2025, then decreased by 2.4% to 0.18 in 2026.
  • Business Quant data shows Debt Ratio for AXSM at 0.18 in Q1 2026, 0.19 in Q4 2025, and 0.19 in Q3 2025.